CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Parkinson's disease - Management
When should I suspect a diagnosis of Parkinson's disease?
- Suspect Parkinson's disease if the person has any of the following characteristic features (which, early in the disease, are usually unilateral, but become bilateral as the disease progresses):
- Bradykinesia (slowness of movement) or hypokinesia (poverty of movement) — for example:
- Reduced facial expression, arm swing, or blinking.
- Difficulty with fine movements such as buttoning clothes and opening jars, or small, cramped handwriting.
- Slow, shuffling gait, or difficulty turning in bed.
- Stiffness or rigidity, which may be:
- Lead-pipe rigidity, which describes the constant resistance felt when a limb is passively flexed in the presence of increased tone without tremor, or
- Cogwheel rigidity, which describes the regular intermittent relaxation of tension felt when a limb is passively flexed in the presence of tremor and increased tone.
- Rest tremor, which:
- Improves on moving.
- May appear at the thumb and index finger ('pill-rolling'), the wrist, or the leg.
- Is absent in up to 30% of people at disease onset.
- Parkinson's disease may be confused with other causes of tremor and parkinsonism — see Differential diagnosis.
- If the person is taking a drug known to cause parkinsonism (that is: an antipsychotic; the anti-emetics, metoclopramide and prochlorperazine; or, less commonly, an antidepressant, amiodarone, cinnarizine, lithium, sodium valproate, or a cholinesterase inhibitor), see Differentiating Parkinson's disease from drug-induced parkinsonism.
In depth
© NHS Institute for Innovation and Improvement